- Prof. Yan-Jiang Wang
Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.
Website | E-mail
- Prof. Sheng Chen
Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Website | E-mail
Special Issue Introduction
COVID-19 patients experienced a wide range of symptoms that affect multiple organs and systems of the body. Neurological symptoms were extremely common, appearing in about 80% of patients who had been hospitalized with COVID-19. Furthermore, COVID-19 causes a variety of neurological sequelae in survivors, including cognitive deficits, dizziness, headache, myalgias, hypogeusia, hyposmia, polyneuropathy, myositis, cerebrovascular diseases, encephalitis, and encephalopathy et al. These long-term neurological outcomes dramatically threaten the quality of life in COVID-19 survivors. Recent research advances have identified the fact that even mild COVID-19 may cause irreversible microstructure damage in the brain, suggesting an intimate association between COVID-19 and brain disorders.
With the increasing amount of the population surviving COVID-19, the long-term neurological consequences should be concerned. Therefore, we launched this special issue to collect advances in the neurological consequences of COVID-19.
This special issue will welcome submissions including but not limited to:
● Clinical investigations about the neurological manifestations and/or sequelae of COVID-19
● Clinical investigations about the consequences of COVID-19 in subjects with neurological diseases
● Studies of the mechanism through which COVID-19 can damage the brain
● Preventative measures to reduce the negative implications in the brain associated with COVID-19
● Treatment of neurological disorders caused by COVID-19
● Opinions and Perspectives that focus on the impact of COVID-19 on the brain (This special issue solicits the submission of Opinion and Perspective articles on both animal and human models that provide editorialized analysis related to the scope of “COVID-19 and the brain” by established researchers in this area of expertise)
COVID-19, SARS-CoV-2, brain, neurology
Submission Deadline15 Dec 2022